Stacie Dusetzina, PhD
Stacie B. Dusetzina, PhD is a pharmacoepidemiologist and health services researcher. Her work focuses on the intersection of health policy and epidemiology, largely in the area of cancer and its treatment. She is an assistant professor the Division of Pharmaceutical Outcomes and Policy in the UNC Eshelman School of Pharmacy and is jointly appointed in the Department of Health Policy and Management in the Gillings School of Global Public Health. In addition to her roles in the School of Pharmacy and the School of Public Health, Dr. Dusetzina is a member of the Lineberger Comprehensive Cancer Center and the Carolina Health Informatics Program (CHIP), and a research fellow at the Cecil G. Sheps Center for Health Services Research.
Dr. Dusetzina’s current research focuses on estimating changes in the utilization and costs of chemotherapy and cost and policy-related barriers to treatment use. She is currently the PI of a grant from the American Cancer Society which seeks to evaluate the impact or oral chemotherapy parity laws on use and spending on chemotherapy. She is also the recipient of an institutional K award that focuses on evaluating novel methods for measuring adherence to supportive therapies among patients with newly diagnosed cancer. In addition to her applied health services research, Dr. Dusetzina is a methodologist with expertise in secondary database studies (Medicare, Medicaid, and private health insurance) and data linkage for comparative effectiveness research.
Dr. Dusetzina received her PhD from the Division of Pharmaceutical Outcomes and Policy at the Eshelman School of Pharmacy in 2010 and her post-doctoral training at the Department of Health Care Policy at Harvard Medical School.
BS, Psychology; Management & Society (dual major), University of North Carolina at Chapel Hill, 2002
PhD, Pharmaceutical Sciences (Epidemiology minor), University of North Carolina at Chapel Hill, 2010
Research Fellow, Health Care Policy, Harvard Medical School, 2012